Gene Query: MPHOSPH10

Dataset Description Geneva Score
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 57.73
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 52.57
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 40.2
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 24.5
FBXW7 modulates stress response by post-translational modification of HSF1 21.9
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 21.9
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 21.63
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 20.65
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 20.65
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 20.32
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 20.32
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 19.89
Human cell line and subcutaneous tumor 17.82
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 17.27
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 17.27
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 17.22
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 17.07
Seletive inhibition of CDK9 in DLBCL cell lines 16.87
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 16.82
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 16.48
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 15.8
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 15.26
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 14.58
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 14.58
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 14.3
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 13.88
Developmental stage specific chromosome architecture in human erythroid cells 13.88
Changes in human endometrial gland transcriptome over the window of implantation 13.29
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 13.28
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 13.26
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 13.11
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 13.03
Peptidomimetic blockade of MYB in acute myeloid leukemia 13.03
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 12.85
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 12.81
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 12.81
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 12.64
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 12.52
Hepatitis C virus functionally sequesters miR-122 12.36
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 12.36
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 12.28
Effect of drugs on transcriptomic profiles 12.12
Total RNA-seq in ALL-SIL upon TLX1 knockdown 12.05
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 11.68
Uridylation by TUT4 and TUT7 marks mRNA for degradation 11.55
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 11.49
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 11.39
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 11.22
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 10.97
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 10.96
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 10.82
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 10.82
HEK293 TFAM Knockout Expression Study 10.63
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 10.61
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 10.44
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 10.34
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 10.16
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 10.11
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 9.99
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 9.92
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 9.83
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 9.79
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 9.65
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 9.56
Knockdown of ADNP in HCT116 colon cancer cells 9.55
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 9.53
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 9.5
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 9.49
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 9.49
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 9.28
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 9.27
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 9.21
U1 snRNP telescripting regulates size-function stratified human genome 9.12
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 9.1
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 9.1
ETV7 and interferon response 9.06
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 9.06
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 9.05
Loss of endometrial plasticity in recurrent pregnancy loss 8.85
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 8.85
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 8.5
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 8.43
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 8.4
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 8.4
Cajal bodies are linked to genome conformation 8.39
Cajal bodies are linked to genome conformation [RNA-Seq] 8.39
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 8.37
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 8.34
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 8.34
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 8.34
hTERT promotes cell adhesion and migration independent of telomerase activity 8.3
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 8.28
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 8.21
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 8.2
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 8.2
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 8.2
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 8.09
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 8.09
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 8.05
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 8.05
Transcriptomic analyssis following EHMT1/2 inhibition 7.99
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 7.99
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 7.91
The evolution of N6-methyladenosine in primates 7.89
Effect of FGF13 depletion on the H460 cell line 7.88
Lysine benzoylation is a novel histone mark [RNA-seq] 7.87
Lysine benzoylation is a novel histone mark 7.87
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 7.86
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 7.86
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 7.85
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 7.82
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 7.76
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 7.75
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 7.75
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 7.64
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 7.64
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 7.64
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 7.62
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 7.6
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 7.56
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 7.53
Cell responses to dysregulated VZV-induced cell-cell fusion 7.52
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 7.47
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 7.46
Genome wide expression change by RNF168 knocking down in NEC cells 7.4
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 7.39
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 7.38
IDH3a KO RNA-seq 7.33
Polarized B -cell functions 7.31
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 7.31
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 7.31
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 7.31
RNA-seq in transgenic cells 7.31
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 7.25
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 7.24
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 7.24
Global Mapping of Human RNA-RNA Interactions 7.21
The regulartory role of ZCCHC24 in splicing machinery 7.13
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 7.11
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 7.07
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 7.02
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 7.0
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 6.97
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 6.96
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 6.96
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 6.9
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 6.87
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 6.84
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 6.76
mRNA expression profile of Lymphocytes 6.76
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 6.73
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 6.7
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 6.67
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 6.67
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 6.61
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 6.6
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 6.57
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 6.56
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 6.54
Global analysis of enhancer targets: Mosaic-seq 6.41
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 6.4
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 6.4
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 6.35
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 6.35
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 6.31
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 6.24
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 6.23
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 6.22
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 6.22
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 6.21
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 6.21
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 6.18
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 6.12
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 6.1
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 6.1
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 6.1
Mapping interactions for the TNIP2 hub protein 6.07
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 6.06
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 6.06
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 6.05
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 6.05
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 6.04
Downregulation of DDX5/DDX17 and REST 6.03
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 6.01
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 5.96
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 5.96
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 5.95
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 5.95
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 5.94
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 5.89
Genome wide miR-191 target profile determined by RIP and gene expression profiling 5.89
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 5.88
RNA-seq in HepG2 and IMR90 cells 5.85
Evolution of a transcriptional regulator from a transmembrane nucleoporin 5.85
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 5.84
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 5.82
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.73
IL-33 activates tumor stroma to promote intestinal polyposis 5.66
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 5.65
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 5.65
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 5.65
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 5.63
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 5.63
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 5.61
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 5.6
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 5.59
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 5.58
A Unique Epigenomic Landscape Defines Human Erythropoiesis 5.57
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 5.57
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 5.55
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.52
CD73 knockdown effect in pancreatic cancer cell lines 5.52
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 5.51
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 5.46
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 5.44
Hijacking of stress response machinery by oncogenes in acute leukaemia 5.44
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 5.32
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 5.26
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 5.24
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 5.22
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 5.22
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 5.22
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 5.18
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 5.18
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 5.14
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 5.08
Hepatocyte maturation 5.07
SLIGRL-induced gene expression changes in NHEK cells 5.04
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 5.01
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 5.01
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 5.0
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 4.96
Neonatal and adult human testis defined at the single-cell level 4.96
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.91
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 4.9
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 4.9
Single-Cell Genotyping of Transcriptomes 4.89
RNA-seq of Single-Cell Genotyping of Transcriptomes 4.89
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 4.87
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 4.85
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 4.85
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 4.84
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 4.77
Co-regulation of splicing by Rbfox1 and hnRNP M 4.76
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 4.76
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 4.75
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 4.74
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 4.72
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 4.71
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 4.7
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 4.64
Gene expression analysis of dengue-infected cells 4.63
Capturing the Interactome of Newly Transcribed RNA 4.6
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.6
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 4.54
RNA sequencing of human mammary epithelial cells 4.53
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 4.53
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.52
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 4.5
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 4.49
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 4.45
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 4.45
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 4.42
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 4.41
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 4.41
MicroRNA-125a-5p overexpression in human macrophages 4.41
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 4.39
Gene expressions of H9s in different culture systems 4.38
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 4.34
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 4.32
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.27
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.21
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 4.16
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 4.14
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 4.1
SETBP1-WT and SETBP1-G870S epigenetic landscapes 4.1
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 4.1
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 4.09
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 4.08
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 4.02
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 4.02
Gene expression analysis upon mtDNA depletion 4.01
Gene expression analysis upon mtDNA depletion [RNA-seq] 4.01
scRNASeq analysis of cycling cardiomyocytes 3.97
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 3.96
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 3.94
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 3.93
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 3.92
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 3.92
Gene expression changes caused by KRAS in MCF-10A 3.89
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.87
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 3.84
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 3.84
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 3.84
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 3.82
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 3.78
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 3.75
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 3.75
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 3.68
RNA-seq analyisis of PUM2 knockout cells 3.66
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 3.65
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.64
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.64
mRNA recovered upon RNF219 IP. [RNA-IP] 3.64
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 3.62
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 3.62
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 3.62
p53 activity results in DNA replication fork processivity 3.52
RNA seq with AML (NB4) cells upon FTO inhibition 3.51
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 3.48
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 3.48
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.47
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 3.46
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.45
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 3.43
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 3.32
The cohesin complex prevents Myc-induced replication stress 3.31
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 3.3
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 3.25
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 3.15
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 3.15
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.1
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 3.1
JunB control of keratinocyte-mediated inflammation [RNA-seq] 3.09
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 3.09
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 3.06
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 2.98
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 2.93
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 2.93
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 2.92
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 2.92
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 2.87
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 2.85
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.84
Solid phase chemistry to covalently and reversibly capture thiolated RNA 2.8
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.77
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 2.74
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.72
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.72
RNA-seq analysis of control and Myc-induced U2OS cells 2.71
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.64
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.64
The role of CFTR in islet function 2.63
Hypoxic transcriptome of SQ20B human head and neck cancer cells 2.59
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.57
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 2.56
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 2.56
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 2.53
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 2.53
RNA-Sequencing of HepG2 cells treated with TGFBeta 2.52
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 2.51
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.49
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.44
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.44
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 2.43
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 2.36
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 2.35
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 2.35
Loss of CREBBP results in gene expression repression in lymphoma cells 2.34
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 2.34
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 2.31
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 2.28
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.25
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 2.24
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 2.24
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 2.24
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.22
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 2.22
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 2.18
U2AF1 mutations alter splice site recognition in hematological malignancies 2.16
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.14
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.09
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 2.07
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.07
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 2.04
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 1.98
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.98
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 1.97
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.97
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.87
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.87
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.84
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 1.84
RNA-Seq of PRMT1 overexpression ECA109 cells 1.75
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.72
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 1.71
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.68
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 1.67
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 1.67
Gene expression profiling in metabolically heterogeneous human lung tumors 1.64
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 1.63
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 1.58
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 1.54
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.51
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.51
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.48
In vitro modeling of human germ cell development using pluripotent stem cells 1.46
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.44
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.44
Discovering human diabetes-risk gene function with genetics and physiological assays 1.42
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 1.41
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.4
Measure transcript integrity using RNA-seq data 1.4
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.36
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.35
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.32
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.32
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 1.3
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 1.3
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.3
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 1.28
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.25
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.24
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.22
Regulation of poly(A) tail and translation during the somatic cell cycle 1.2
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.19
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.19
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.19
The contribution of Alu exons to the human proteome 1.06
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 1.06
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 1.04
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 1.03
Metastasis in triple-negative breast cancer 1.03
Genome-wide analysis of the Integrator complex (HTS) 1.01
Genome-wide analysis of the Integrator complex 1.01
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 1.01
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.99
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.98
Impact on erythroid progenitor type on erythroid differntiation 0.97
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.97
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.95
Transcriptome-wide modulation of splicing by the exon junction complex 0.95
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.94
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.94
Aneuploidy-induced cellular stresses limit autophagic degradation. 0.94
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.94
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.93
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.91
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.91
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.9
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.89
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.82
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.82
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.8
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.8
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.76
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.75
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.75
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 0.71
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.66
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.66
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.64
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.64
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.58
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.56
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.56
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.55
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.54
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.53
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.53
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 0.53
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.47
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 0.47
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 0.47
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 0.45
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 0.42
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 0.39
Small-molecule targeting of brachyury transcription factor addiction in chordoma 0.38
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.38
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.38
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.37
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.37
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.37
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.35
SNHG5 siRNA knock down in HCT116 cells 0.33
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.33
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.33
siRNA-mediated knockdown 0.32
HBEC-shp53-PCHD7 0.3
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.22
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.21
Transcriptional landscape changes during human embryonic stem cell derivation 0.2
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 0.17
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.17
Gene expression changes due to PARP knockdown in human cells 0.11
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.1
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.1
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.1
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.1
RNA-seq data 0.09
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.09
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.08
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.07
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.06
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.06
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.06
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.06
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.04
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation